![Luis Borges](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Luis Borges
Technik-/Wissenschafts-/F&E-Leiter bei METAGENOMI, INC.
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Luis Borges
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
METAGENOMI, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2023 | - |
Karriereverlauf von Luis Borges
Ehemalige bekannte Positionen von Luis Borges
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTURY THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 | 01.07.2023 |
FIVE PRIME THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.02.2015 | 01.06.2015 |
Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 | 01.03.2019 | |
Corporate Officer/Principal | 01.05.2014 | 01.01.2015 | |
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 | 01.03.2019 |
AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2011 | 01.04.2014 |
Metagenomi Technologies LLC
![]() Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2023 | - |
Ausbildung von Luis Borges
University of Lisbon | Undergraduate Degree |
University of Washington | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Portugal | 2 |
Vereinigtes Königreich | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 7 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
AMGEN INC. | Health Technology |
CENTURY THERAPEUTICS, INC. | Health Technology |
METAGENOMI, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Five Prime Therapeutics, Inc.
![]() Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Metagenomi Technologies LLC
![]() Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
- Börse
- Insiders
- Luis Borges
- Erfahrung